 |
39 Diseases |  |
32 Trials |
|
32 Trials |  |
385 News |  |
| «123456» |
- | Enrollment closed: SHAPE2: Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women (clinicaltrials.gov) - Jul 12, 2017
P, N=100, Active, not recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Active, not recruiting
- | progesterone / Generic mfg.
New P4 trial: Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles (clinicaltrials.gov) - Jun 9, 2017
P4, N=60, Recruiting, Sponsor: Andros Day Surgery Clinic
- ||| Cetrotide (cetrorelix) / EMD Serono
Trial completion, Retrospective data: FASSION: A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment (clinicaltrials.gov) - May 18, 2017
P=N/A, N=3000, Completed, Sponsor: Merck KGaA
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Cetrotide (cetrorelix) / EMD Serono
New P2/3 trial: Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality (clinicaltrials.gov) - May 4, 2017
P2/3, N=120, Not yet recruiting, Sponsor: Assiut University
- Cetrotide (cetrorelix) / EMD Serono
Enrollment change: Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression (clinicaltrials.gov) - May 1, 2017
P=N/A, N=5, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed N=165 --> 5
- | Cetrotide (cetrorelix) / EMD Serono
New P4 trial: Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI (clinicaltrials.gov) - Apr 18, 2017
P4, N=100, Not yet recruiting, Sponsor: Cairo University
- | Cetrotide (cetrorelix) / EMD Serono
Biomarker, Enrollment closed, Trial primary completion date: Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Mar 30, 2017
P2/3, N=48, Active, not recruiting, Sponsor: Benha University
N=165 --> 5 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Apr 2017
- | Cetrotide (cetrorelix) / EMD Serono
Enrollment open, Trial initiation date, Trial primary completion date: Random-start Ovarian Stimulation in Egg-donors (ROSE) (clinicaltrials.gov) - Feb 28, 2017
P4, N=30, Recruiting, Sponsor: Instituto Bernabeu
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Apr 2017 Not yet recruiting --> Recruiting | Initiation date: Jul 2016 --> Jan 2017 | Trial primary completion date: Nov 2016 --> Jul 2017
- Firmagon (degarelix) / Astellas, Ferring, Cetrotide (cetrorelix) / EMD Serono
Trial primary completion date: Dysregulation of FSH in Obesity: Functional and Statistical Analysis (clinicaltrials.gov) - Jan 17, 2017
P=N/A, N=68, Recruiting, Sponsor: University of Colorado, Denver
Not yet recruiting --> Recruiting | Initiation date: Jul 2016 --> Jan 2017 | Trial primary completion date: Nov 2016 --> Jul 2017 Trial primary completion date: Dec 2016 --> Jul 2017
- ||| Cetrotide (cetrorelix) / EMD Serono
Enrollment open, Retrospective data: FASSION: A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment (clinicaltrials.gov) - Oct 12, 2016
P=N/A, N=3000, Recruiting, Sponsor: Merck KGaA
Trial primary completion date: Dec 2016 --> Jul 2017 Not yet recruiting --> Recruiting
- || letrozole / Generic mfg.
New P3 trial: Letrozole in Stimulated IVF Cycles (clinicaltrials.gov) - Sep 22, 2016
P3, N=900, Not yet recruiting, Sponsor: The University of Hong Kong
- | Cetrotide (cetrorelix) / EMD Serono
New P4 trial, Preclinical: NATOS: NATural Ovarian Stimulation (clinicaltrials.gov) - Sep 8, 2016
P4, N=320, Not yet recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
- ||| Cetrotide (cetrorelix) / EMD Serono
New trial, Retrospective data: FASSION: A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment (clinicaltrials.gov) - Sep 6, 2016
P=N/A, N=3000, Not yet recruiting, Sponsor: Merck KGaA
- Cetrotide (cetrorelix) / EMD Serono
Biomarker, New P2/3 trial: Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Jul 6, 2016
P2/3, N=48, Recruiting, Sponsor: Benha University
- Cetrotide (cetrorelix) / EMD Serono
New P4 trial: Random-start Ovarian Stimulation in Egg-donors (ROSE) (clinicaltrials.gov) - Jul 5, 2016
P4, N=30, Not yet recruiting, Sponsor: Instituto Bernabeu
- Cetrotide (cetrorelix) / EMD Serono
New trial, Biopsy: PGSvitfreov: PGS on Blastocysts From Vitrified and Fresh Oocytes (clinicaltrials.gov) - Jul 1, 2016
P=N/A, N=60, Completed, Sponsor: Unità di Medicina della Riproduzione, Italy
- | Cetrotide (cetrorelix) / EMD Serono
Trial completion, Enrollment change: Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles (clinicaltrials.gov) - Jun 11, 2016
P2/3, N=100, Completed, Sponsor: National and Kapodistrian University of Athens
Not yet recruiting --> Recruiting Recruiting --> Completed | N=150 --> 100
- | Cetrotide (cetrorelix) / EMD Serono
New P2 trial: Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - May 27, 2016
P2, N=84, Completed, Sponsor: Ain Shams University
- Firmagon (degarelix) / Astellas, Ferring, Cetrotide (cetrorelix) / EMD Serono
Trial primary completion date: Dysregulation of FSH in Obesity: Functional and Statistical Analysis (clinicaltrials.gov) - May 13, 2016
P=N/A, N=68, Recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Completed | N=150 --> 100 Trial primary completion date: Jul 2016 --> Dec 2016
- | Firmagon (degarelix) / Astellas, Ferring
Trial completion, Trial primary completion date: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) (clinicaltrials.gov) - Apr 28, 2016
P3, N=80, Completed, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Trial primary completion date: Jul 2016 --> Dec 2016 Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2015
- Cetrotide (cetrorelix) / EMD Serono
Trial primary completion date: Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles (clinicaltrials.gov) - Apr 7, 2016
P2/3, N=150, Recruiting, Sponsor: National and Kapodistrian University of Athens
Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Dec 2015 --> May 2016
- | Cetrotide (cetrorelix) / EMD Serono
Trial completion: Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase (clinicaltrials.gov) - Jan 27, 2016
P3, N=60, Completed, Sponsor: Cairo University
Trial primary completion date: Dec 2015 --> May 2016 Recruiting --> Completed
- Merional (menotropin) / IBSA Institute Biochemical SA, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA, Cetrotide (cetrorelix) / EMD Serono
New trial, Preclinical: Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program (clinicaltrials.gov) - Dec 29, 2015
P0, N=216, Completed, Sponsor: Cairo University
- Firmagon (degarelix) / Astellas, Ferring, Cetrotide (cetrorelix) / EMD Serono
Enrollment open: Dysregulation of FSH in Obesity: Functional and Statistical Analysis (clinicaltrials.gov) - Nov 14, 2015
P=N/A, N=68, Recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Completed Not yet recruiting --> Recruiting
- Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
Trial completion, Trial primary completion date: IVF/ICSI Protocols in Poor Responders With Growth Hormone (clinicaltrials.gov) - Oct 20, 2015
P4, N=287, Completed, Sponsor: Woman's Health University Hospital, Egypt
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Jan 2015
- Cetrotide (cetrorelix) / EMD Serono
Trial primary completion date: Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles (clinicaltrials.gov) - Sep 24, 2015
P2/3, N=150, Recruiting, Sponsor: National and Kapodistrian University of Athens
Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Jan 2015 Trial primary completion date: Feb 2014 --> Dec 2015
- Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
Trial completion, Preclinical: Antagonist Protocol in Poor Responders (clinicaltrials.gov) - Aug 11, 2015
P4, N=120, Completed, Sponsor: Cairo University
Trial primary completion date: Feb 2014 --> Dec 2015 Active, not recruiting --> Completed
- | Cetrotide (cetrorelix) / EMD Serono, Zorbtive (somatropin) / EMD Serono
Trial completion, Preclinical, Trial primary completion date: Growth Hormone for Poor Responders in in Vitro Fertilization (IVF) (clinicaltrials.gov) - Jul 1, 2015
P2, N=38, Completed, Sponsor: Ottawa Fertility Centre
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Sep 2011 --> May 2015
- Firmagon (degarelix) / Astellas, Ferring, Cetrotide (cetrorelix) / EMD Serono
New trial: Dysregulation of FSH in Obesity: Functional and Statistical Analysis (clinicaltrials.gov) - Jun 23, 2015
P=N/A, N=68, Not yet recruiting, Sponsor: University of Colorado, Denver
- Cetrotide (cetrorelix) / EMD Serono
Biomarker, New trial: Biomarkers of Ovarian Reserve and Correlation With IVF Treatments (clinicaltrials.gov) - May 13, 2015
P=N/A, N=236, Completed, Sponsor: U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti
- Cetrotide (cetrorelix) / EMD Serono, Lutrelef (gonadorelin acetate) / Ferring
Trial completion: Reproductive Hormonal Alterations in Obesity (clinicaltrials.gov) - Mar 28, 2015
P=N/A, N=62, Completed, Sponsor: University of Colorado, Denver
Recruiting --> Completed | Trial primary completion date: Sep 2011 --> May 2015 Active, not recruiting --> Completed
- Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
Enrollment closed, Preclinical, Trial primary completion date: Antagonist Protocol in Poor Responders (clinicaltrials.gov) - Mar 25, 2015
P4, N=120, Active, not recruiting, Sponsor: Cairo University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Jul 2015
- Cetrotide (cetrorelix) / EMD Serono
Clinical: Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) (clinicaltrials.gov) - Mar 19, 2015
P=N/A, N=40, Not yet recruiting, Sponsor: Eugonia
- | Cetrotide (cetrorelix) / EMD Serono
Trial initiation date, Trial primary completion date: Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase (clinicaltrials.gov) - Mar 9, 2015
P3, N=60, Recruiting, Sponsor: Cairo University
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Jul 2015 Initiation date: Jan 2013 --> Jan 2015 | Trial primary completion date: Mar 2015 --> Mar 2016
- Firmagon (degarelix) / Astellas, Ferring
Trial primary completion date: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) (clinicaltrials.gov) - Feb 5, 2015
P3, N=80, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Initiation date: Jan 2013 --> Jan 2015 | Trial primary completion date: Mar 2015 --> Mar 2016 Trial primary completion date: Oct 2014 --> Jun 2015
- | Cetrotide (cetrorelix) / EMD Serono
New P2 trial, Preclinical: Antagonist Protocol in IVF (clinicaltrials.gov) - Jan 12, 2015
P2, N=200, Recruiting, Sponsor: Woman's Health University Hospital, Egypt
- || Cetrotide (cetrorelix) / EMD Serono
New P3 trial: Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase (clinicaltrials.gov) - Jan 7, 2015
P3, N=60, Recruiting, Sponsor: Cairo University
- | clomifene citrate / Generic mfg.
New P4 trial: Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF (clinicaltrials.gov) - Jul 28, 2014
P4, N=250, Recruiting, Sponsor: Bioroma
- | Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
New P4 trial, Preclinical: Antagonist Protocol in Poor Responders (clinicaltrials.gov) - Jul 21, 2014
P4, N=120, Recruiting, Sponsor: Cairo University
- Cetrotide (cetrorelix) / EMD Serono
Preclinical, Trial withdrawal: Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS) (clinicaltrials.gov) - Jun 18, 2014
P1/2, N=0, Withdrawn, Sponsor: Wolfson Medical Center
Trial primary completion date: Oct 2014 --> Jun 2015 Terminated --> Withdrawn
- Trial primary completion date: Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=43, Completed, Sponsor: Main Line Fertility Center
Terminated --> Withdrawn Trial primary completion date: Apr 2013 --> May 2014
- | Trial completion: Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=43, Completed, Sponsor: Main Line Fertility Center
Trial primary completion date: Apr 2013 --> May 2014 Recruiting --> Completed
- Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
Trial initiation date: IVF/ICSI Protocols in Poor Responders With Growth Hormone (clinicaltrials.gov) - Mar 3, 2014
P4, N=287, Recruiting, Sponsor: Woman's Health University Hospital, Egypt
Recruiting --> Completed Initiation date: Jul 2011 --> Sep 2013
- | Cetrotide (cetrorelix) / EMD Serono
Enrollment open: Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles (clinicaltrials.gov) - Nov 28, 2013
P2/3, N=150, Recruiting, Sponsor: National and Kapodistrian University of Athens
Initiation date: Jul 2011 --> Sep 2013 Not yet recruiting --> Recruiting
- | letrozole / Generic mfg.
New P4 trial, Preclinical: The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization. (clinicaltrials.gov) - Sep 5, 2013
P4, N=100, Not yet recruiting, Sponsor: Pınar Özcan Cenksoy
- | Cetrotide (cetrorelix) / EMD Serono
New P4 trial: Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders (clinicaltrials.gov) - Aug 18, 2013
P4, N=500, Not yet recruiting, Sponsor: Huang Rui
- Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
Enrollment open: IVF/ICSI Protocols in Poor Responders With Growth Hormone (clinicaltrials.gov) - Jul 10, 2013
P4, N=287, Recruiting, Sponsor: Woman's Health University Hospital, Egypt
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
New P4 trial: IVF/ICSI Protocols in Poor Responders With Growth Hormone (clinicaltrials.gov) - Jul 9, 2013
P4, N=287, Recruiting, Sponsor: Woman's Health University Hospital, Egypt
- |||| Menopur (menotropin) / Ferring
Trial completion, Preclinical: PREDICT: Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF) (clinicaltrials.gov) - Jul 3, 2013
P4, N=124, Completed, Sponsor: Ferring Pharmaceuticals
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||||| Cetrotide (cetrorelix) / EMD Serono
Trial completion: ATTAC-PCO: Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) (clinicaltrials.gov) - Jul 1, 2013
P3, N=136, Completed, Sponsor: Merck KGaA
Active, not recruiting --> Completed Active, not recruiting --> Completed